Hiroyuki Murakami1*, Ryota Chijimatsu, PhD2*, Hideki Ujiie3*, Yusuke Naoi, MD1*, Kazutaka Sunami, MD, PhD4, Kazuhiko Yamamoto, MD, PhD5*, Soichiro Fujii, MD, PhD6*, Tomofumi Yano, MD, PhD7*, Keisuke Seike, MD, PhD8*, Hideaki Fujiwara, MD, PhD8, Noboru Asada, MD, PhD8, Nobuharu Fujii, MD, PhD9*, Ken-ichi Matsuoka, MD, PhD8*, Tomohiro Urata, MD1*, Kazuhiro Ikeuchi, MD1*, Hiroki Kobayashi, MD10*, Yasuharu Sato, PhD11*, Shuta Tomida, PhD12*, Yoshinobu Maeda, MD, PhD1 and Daisuke Ennishi, MD, PhD13
1Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2Center of Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan
3Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan
4Department of Hematology, NHO, Okayama Medical Center, Okayama, Japan
5Department of Hematology and Oncology, Okayama City Hospital, Okayama, Japan
6Department of Hematology, Japanese Red Cross Okayama Hospital, Okayama, Japan
7Department of Internal Medicine, Okayama Rosai Hospital, Okayama, Japan
8Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
9Division of Blood Transfusion, Okayama University Hospital, Okayama, Japan
10Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, OKA, Japan
11Department of Molecular Hematopathology, Okayama University, Okayama, Japan
12Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sci, Okayama, JPN
13Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan